NuVasive | NUVA - Umsatzerlöse



Der Umsatz Veränderung Datum
Abbott USD 13.01B 423M 2026-09
AtriCure USD 154.45M 850K 2026-09
Baxter International USD 2.98B 20M 2026-09
Becton, Dickinson and Co. USD 5.3B 300M 2026-09
Boston Scientific USD 5.14B 300M 2026-09
Cooper Companies USD 1.07B 15.3M 2026-06
Dexcom USD 1.34B 30M 2026-09
Edwards Lifesciences USD 1.72B 20M 2026-09
Globus Medical USD 763.72M 25.89M 2026-09
Haemonetics USD 357.76M 18.76M 2026-09
Inogen USD 74.93M 504K 2024-09
Insulet USD 842M 40.3M 2026-09
Integra LifeSciences USD 411.18M 7.62M 2026-09
Intuitive Surgical USD 3.05B 158.7M 2026-09
J&J USD 25.4B 89M 2026-09
Medtronic USD 9.8B 0 2026-06
Merit Medical Systems USD 416.24M 2.56M 2026-09
Orthofix International USD 219.91M 14.28M 2025-12
Stryker USD 6.5B 100M 2026-09
Tandem Diabetes Care USD 283.69M 29.09M 2026-09
Teleflex USD 567.8M 2.5M 2026-09
Zimmer Biomet Holdings USD 2.06B 120M 2026-09